Tfg Advisers LLC Abbott Laboratories Transaction History

Tfg Advisers LLC

$274 Million
Q3 2024

A detailed history of Tfg Advisers LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Tfg Advisers LLC holds 5,871 shares of ABT stock, worth $696,300. This represents 0.24% of its overall portfolio holdings.

Number of Shares

5,871

Previous 6,150 4.54%

Holding current value

$696,300

Previous $639,000 4.69%

% of portfolio

0.24%

Previous 0.25%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$100.07 - $118.13 $27,919 - $32,958	-279 Reduced 4.54%	5,871 $669,000
Q2 2024 Jul 25, 2024	SELL	$100.73 - $112.44 $39,486 - $44,076	-392 Reduced 5.99%	6,150 $639,000
Q1 2024 May 06, 2024	BUY	$109.52 - $120.96 $11,609 - $12,821	106 Added 1.65%	6,542 $743,000
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $12,265 - $15,014	136 Added 2.16%	6,436 $708,000
Q3 2023 Oct 19, 2023	BUY	$95.53 - $114.62 $25,888 - $31,062	271 Added 4.49%	6,300 $610,000
Q2 2023 Jul 19, 2023	BUY	$100.78 - $112.29 $22,272 - $24,816	221 Added 3.81%	6,029 $657,000
Q1 2023 May 02, 2023	BUY	$96.86 - $114.01 $968 - $1,140	10 Added 0.17%	5,808 $588,000
Q4 2022 Feb 01, 2023	BUY	$95.06 - $111.52 $4,467 - $5,241	47 Added 0.82%	5,798 $636,000
Q3 2022 Oct 21, 2022	BUY	$96.76 - $112.03 $9,966 - $11,539	103 Added 1.82%	5,751 $557,000
Q2 2022 Jul 20, 2022	BUY	$102.07 - $123.37 $1,122 - $1,357	11 Added 0.2%	5,648 $614,000
Q1 2022 Apr 20, 2022	BUY	$114.02 - $139.04 $11,287 - $13,764	99 Added 1.79%	5,637 $667,000
Q4 2021 Feb 01, 2022	BUY	$115.53 - $141.46 $1,039 - $1,273	9 Added 0.16%	5,538 $779,000
Q3 2021 Oct 21, 2021	BUY	$116.66 - $129.06 $1,516 - $1,677	13 Added 0.24%	5,529 $653,000
Q2 2021 Jul 19, 2021	BUY	$105.79 - $124.53 $14,704 - $17,309	139 Added 2.59%	5,516 $640,000
Q1 2021 Apr 23, 2021	BUY	$108.84 - $128.23 $34,719 - $40,905	319 Added 6.31%	5,377 $644,000
Q4 2020 Feb 02, 2021	SELL	$105.0 - $114.42 $22,050 - $24,028	-210 Reduced 3.99%	5,058 $553,000
Q3 2020 Nov 02, 2020	SELL	$91.64 - $111.29 $549 - $667	-6 Reduced 0.11%	5,268 $573,000
Q2 2020 Aug 04, 2020	BUY	$76.57 - $98.0 $11,255 - $14,406	147 Added 2.87%	5,274 $482,000
Q1 2020 Apr 24, 2020	SELL	$62.82 - $91.86 $691 - $1,010	-11 Reduced 0.21%	5,127 $404,000
Q4 2019 Mar 16, 2020	BUY	$78.51 - $87.4 $942 - $1,048	12 Added 0.23%	5,138 $446,000
Q3 2019 May 01, 2020	BUY	$81.84 - $88.74 $982 - $1,064	12 Added 0.23%	5,126 $428,000
Q2 2019 May 01, 2020	BUY	$72.88 - $85.0 $9,838 - $11,475	135 Added 2.71%	5,114 $430,000
Q1 2019 Apr 30, 2020	SELL	$66.22 - $80.06 $14,038 - $16,972	-212 Reduced 4.08%	4,979 $398,000
Q4 2018 Apr 29, 2020	BUY	$65.56 - $74.27 $340,321 - $385,535	5,191 New	5,191 $375,000

Others Institutions Holding ABT

# of Institutions

3,167

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfg Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tfg Advisers LLC with notifications on news.

Account